Chemoinformaics analysis of 5-hydroxy-7-methoxyflavanone
| Molecular Weight | 270.284 | nRot | 2 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 18 |
| Exact Molecular Weight | 270.089 | nRing | 3 |
| Solubility: LogS | -4.451 | nHRing | 1 |
| Solubility: LogP | 3.41 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 39.2631 |
| nHD | 1 | BPOL | 18.3849 |
| QED | 0.911 |
| Synth | 2.59 |
| Natural Product Likeliness | 1.329 |
| NR-PPAR-gamma | 0.934 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.059 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.66 |
| MDCK | 0.0000175 |
| BBB | 0.27 |
| PPB | 0.97067 |
| VDSS | 0.532 |
| FU | 0.0216526 |
| CYP1A2-inh | 0.938 |
| CYP1A2-sub | 0.831 |
| CYP2c19-inh | 0.956 |
| CYP2c19-sub | 0.453 |
| CYP2c9-inh | 0.899 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.872 |
| CYP2d6-sub | 0.86 |
| CYP3a4-inh | 0.78 |
| CYP3a4-sub | 0.234 |
| CL | 9.462 |
| T12 | 0.228 |
| hERG | 0.047 |
| Ames | 0.358 |
| ROA | 0.5 |
| SkinSen | 0.513 |
| Carcinogencity | 0.541 |
| EI | 0.938 |
| Respiratory | 0.863 |
| NR-Aromatase | 0.046 |
| Antiviral | Yes |
| Prediction | 0.707137 |